NicOx Expects To File NDA For Osteoarthritis Drug In 2009
The French company says it would need a partner to launch the drug, a potential competitor to Pfizer’s Celebrex.
The French company says it would need a partner to launch the drug, a potential competitor to Pfizer’s Celebrex.